CMOS and beyond CMOS
Discover why imec is the premier R&D center for advanced logic & memory devices. anced logic & memory devices.
Connected health solutions
Explore the technologies that will power tomorrow’s wearable, implantable, ingestible and non-contact devices.
Life sciences
See how imec brings the power of chip technology to the world of healthcare.
Sensor solutions for IoT
Dive into innovative solutions for sensor networks, high speed networks and sensor technologies.
Artificial intelligence
Explore the possibilities and technologies of AI.
More expertises
Discover all our expertises.
Research
Be the first to reap the benefits of imec’s research by joining one of our programs or starting an exclusive bilateral collaboration.
Development
Build on our expertise for the design, prototyping and low-volume manufacturing of your innovative nanotech components and products.
Solutions
Use one of imec’s mature technologies for groundbreaking applications across a multitude of industries such as healthcare, agriculture and Industry 4.0.
Venturing and startups
Kick-start your business. Launch or expand your tech company by drawing on the funds and knowhow of imec’s ecosystem of tailored venturing support.
/Reading room/Imec and CARDIS partners develop unique photonic-based medical device for the screening of arterial stiffness and the diagnosis of cardiovascular diseases

Press release

Imec and CARDIS partners develop unique photonic-based medical device for the screening of arterial stiffness and the diagnosis of cardiovascular diseases

About CARDIS

The CARDIS project has received funding from the European Union's H2020 Programme for research, technological development and demonstration under grant agreement No  644798. Coordinated by imec and Medtronic, the project partners include SIOS Messtechnik GmbH (Germany), Tyndall (Ireland), Ghent University (Belgium), INSERM (France), Queen Mary University of London (UK), Maastricht University (The Netherlands) and Fundico (Belgium).

About imec

Imec is the world-leading research and innovation hub in nanoelectronics and digital technologies. The combination of our widely acclaimed leadership in microchip technology and profound software and ICT expertise is what makes us unique. By leveraging our world-class infrastructure and local and global ecosystem of partners across a multitude of industries, we create groundbreaking innovation in application domains such as healthcare, smart cities and mobility, logistics and manufacturing, energy and education.

As a trusted partner for companies, start-ups and universities we bring together more than 4,000 brilliant minds from over 85 nationalities. Imec is headquartered in Leuven, Belgium and has distributed R&D groups at a number of Flemish universities, in the Netherlands, Taiwan, USA, China, and offices in India and Japan. In 2017, imec's revenue (P&L) totaled 546 million euro. Further information on imec can be found at www.imec-int.com.

Imec is a registered trademark for the activities of IMEC International (a legal entity set up under Belgian law as a "stichting van openbaar nut”), imec Belgium (IMEC vzw supported by the Flemish Government), imec the Netherlands (Stichting IMEC Nederland, part of Holst Centre which is supported by the Dutch Government), imec Taiwan (IMEC Taiwan Co.) and imec China (IMEC Microelectronics (Shanghai) Co. Ltd.) and imec India (Imec India Private Limited), imec Florida (IMEC USA nanoelectronics design center).

About Photonics Research Group

The Photonics Research Group in the Department of Information Technology of Ghent University is an associated lab of imec and performs research in the field of photonic integration – more specifically silicon photonics – and its applications in information and communication technology, in sensing and in life sciences. With its 80 researchers the group has a leading international role in the field and is also very active in graduate education in photonics and in industrial spin-off resulting from its research. More information can be found at www.photonics.intec.ugent.be.

About Medtronic

Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 86,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Medtronic Bakken Research Center (BRC), founded by Medtronic in Maastricht in 1987, starting with 45 employees and now reaching 325, is the research facility involved in CARDIS. Especially clinical study activities have grown substantially, now ranging from small exploratory studies with one physician-investigator and just a few patients to multinational, randomized trials intended to demonstrate superior clinical and economical outcomes with new device therapies in hundreds, sometimes thousands of patients. The BRC nowadays also hosts the Benelux Therapy & Procedure Training Center, where advanced simulator training is offered to physicians, nurses and technicians.

This website uses cookies for analytics purposes only without any commercial intent. Find out more here. Our privacy statement can be found here. Some content (videos, iframes, forms,...) on this website will only appear when you have accepted the cookies.